Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-055081
Filing Date
2026-05-12
Accepted
2026-05-12 16:16:04
Documents
66
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0286988-10q_therapeutics.htm   iXBRL 10-Q 453632
2 CERTIFICATION ea028698801ex31-1.htm EX-31.1 17299
3 CERTIFICATION ea028698801ex31-2.htm EX-31.2 12017
4 CERTIFICATION ea028698801ex32-1.htm EX-32.1 6762
5 CERTIFICATION ea028698801ex32-2.htm EX-32.2 6768
  Complete submission text file 0001213900-26-055081.txt   4057593

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE txmd-20260331.xsd EX-101.SCH 44892
7 XBRL CALCULATION FILE txmd-20260331_cal.xml EX-101.CAL 38298
8 XBRL DEFINITION FILE txmd-20260331_def.xml EX-101.DEF 183906
9 XBRL LABEL FILE txmd-20260331_lab.xml EX-101.LAB 391791
10 XBRL PRESENTATION FILE txmd-20260331_pre.xml EX-101.PRE 214396
69 EXTRACTED XBRL INSTANCE DOCUMENT ea0286988-10q_therapeutics_htm.xml XML 362157
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 26968781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)